Quarterly report [Sections 13 or 15(d)]

EARNINGS (LOSS) PER SHARE (Tables)

v3.25.3
EARNINGS (LOSS) PER SHARE (Tables)
9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share
The reconciliations of the net loss and the weighted average number of shares used in the computations of basic and diluted loss per share are as follows:
Three Months Ended September 30, Nine Months Ended September 30,
2025 2024 2025 2024
Numerator:
Net loss
$ (23,689) $ (16,016) $ (53,035) $ (36,309)
Denominator:
Weighted-average shares of common stock - basic and diluted
195,196,597  195,165,913  195,196,597  195,145,417 
Loss per common share:
Basic and diluted
$ (0.12) $ (0.08) $ (0.27) $ (0.19)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following table summarizes weighted average instruments that may, in the future, have a dilutive effect on earnings (loss) per share, but were excluded from consideration in the computation of diluted net loss per share for the three and nine months ended September 30, 2025 and 2024, because the impact of including them would have been anti-dilutive:
Three Months Ended September 30, Nine Months Ended September 30,
2025 2024 2025 2024
Stock options 24,243,562  26,537,311  24,817,114  27,402,967 
Warrants (derivative liabilities and equity) 80,129,162  101,726,848  78,392,223  92,766,898 
Unvested restricted stock awards —  1,679  —  1,800 
104,372,724  128,265,838  103,209,337  120,171,665